The role of appetite-controlling hormones in the development of eating disorders in diabetic 2 patients

Binge eating disorder (BED) and night eating syndrome (NES) are common eating disorders (EDs) in individuals with diabetes type 2 (DT2). They worsen metabolic control, have a negative impact on physical and mental health and reduce quality of life. The roles of appetite-controlling hormones – leptin...

Full description

Saved in:
Bibliographic Details
Published in:Current issues in pharmacy and medical sciences 2022-08, Vol.35 (2), p.86-88
Main Authors: Urbanovych, Alina, Laniush, Fedir
Format: Article
Language:English
Subjects:
binge eating
Diabetes
diabetes type 2
Eating disorders
ghrelin
leptin
Metabolism
night eating syndrome
obesity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Binge eating disorder (BED) and night eating syndrome (NES) are common eating disorders (EDs) in individuals with diabetes type 2 (DT2). They worsen metabolic control, have a negative impact on physical and mental health and reduce quality of life. The roles of appetite-controlling hormones – leptin and ghrelin – is not clear enough in EDs and need to be investigated in order to establish new approaches and markers of EDs. Aim: To assess the difference in leptin and ghrelin levels in DT2 patients with and without EDs. 57 patients with DT2 were involved in the study. After physical examination and screening for EDs, blood samples for leptin and ghrelin measuring were obtained. Results: 19 participants (33.3%) were screened positively for ED (BE or NES). Leptin levels were higher in participants with ED (p
ISSN:2300-6676
2084-980X
2300-6676
DOI:10.2478/cipms-2022-0016